Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer (NCT06997094) | Mayo Clinic | 2026-01-23 |
Track Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.